Plevral Effüzyonların Değerlendirilmesi: Malign ve Paramalign

Yıl 2020, Cilt: 6 Sayı: 2, 203 - 208, 01.01.2020

Miktat Arif Haberal Ozlem Sengoren Dıkıs Erkan Akar

Öz

Amaç: Malign plevral effüzyonlar MPE plevral sıvıda malign hücre görülmesi ile karakterizedir. Paramalign plevral effüzyonlar PMPE ise bronş tıkanması, lenfatiklerin obstrüksiyon gibi sekonder sebeplere bağlı sıvı birikimi ile oluşur. PMPE malign hücre içermez. Çalışmamızda MPE ve PMPE’lu hastaların sonuçlarını karşılaştırmayı amaçladık.Gereç ve Yöntemler: Yüz yetmiş altı hasta MPE: 145 PMPE: 31 retrospektif olarak incelendi. Hastalar MPE ve PMPE olarak 2 gruba ayrıldı. Hastaların yaşı, cinsiyeti, semptomları, yaşamsal belirtileri, komorbid hastalığı, hastalığın yeri iki taraflı efüzyonlu hastalarda cerrahi işlemlerin yapıldığı yer , tanı prosedürleri, cerrahi işlemler, komplikasyonlar, kalış süresi, mortalite ve morbidite incelendi. Sonuçlar analiz edildi. P

Anahtar Kelimeler

Plevral effüzyon, Malign, Paramalign, Cerrahi, Video yardımlı toraks cerrahisi

Evaluation of Pleural Effusions: Malignant and Paramalignant

Öz

Objective: Malignant pleural effusions MPE are characterized by the presence of malignant cells in the pleural fluid. Paramalignant pleural effusions PMPE are caused by the accumulation of fluid due to secondary causes such as bronchial obstruction and lymphatic obstruction. PMPE does not contain malignant cells. We aimed to compare the results of patients with MPE and PMPE.Material and Methods: 176 patients MPE: 145 PMPE: 31 were analysed retrospectively. Patients were divided into 2 groups as MPE, and PMPE. The patients' age, sex, symptoms, vital signs, comorbid disease, disease location the place where surgical procedures were performed was taken into account in patients with bilateral effusions , diagnostic procedures, surgical procedures, complications, length of stay, mortality and morbidity were examined. Results were analysed. P

Anahtar Kelimeler

Pleural effusion, Malign, Paramalignant, Surgery, Video-assisted thoracic surgery

Kaynakça

• Ozdulger A, Ulubas B. Plevral efuzyonlar ve plevra tuberkulozu. In: Yuksel M, Balcı AE, eds. Göğüs cerrahisi, 2th ed. Istanbul: Nobel Tıp Kitabevi, 2015: 529-39.
• Bielsa S, Martin-Juan J, M. Porcel J, Rodriguez-Panadero F. Diagnostic and prognostic implications of pleural adhesions in malignant effusions. J Thorac Oncol 2008; 3:1251-6.
• Sahn S. The value of pleural fluid analysis. Am J Med Sci 2008; 335:7-15.
• Light RW, Hamm H. Malignant pleural effusion: Would the real cause please stand up? Eur Respir J 1997; 10:1701- 2.
• Chernow B, Sahn SA. Carcinomatous involvement of the pleura: An analysis of 96 patients. Am J Med 1997; 63:695-702.
• Detterbeck FC, Jones DR, Morris DE. Palliative treatment of lung cancer. In: Detterbeck FC, Rivera MP, Socinski MA, Rosenman JG, eds. Diagnosis and treatment of lung cancer. Philadelphia: WB Saunders Company, 2001: 428- 33.
• Kitabevi, 2013: 1585-601.
• Sahn SA. Pleural effusion of extravascular origin. Clin Chest Med 2006; 27:285-308.
• Harber P, Gee JBL. Clinicians’ approach to mesothelioma. In: Pass HI, Vogelzang N, Carbone M, eds. Malignant mesothelioma. New York: Springer, 2005: 266-364.
• Baldini EH. Radiation therapy options for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 2009; 21:159-63.
• Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician 2006; 73:1211-20.
• Brims FJH, Davies HE, Gary Lee YC. Respiratory chest pain: Diagnosis and treatment. Med Clin North Am 2010; 94:217-32.
• Helm EJ, Matin TN, Gleeson FV. Imaging of the pleura. J Magn Reson Imaging 2010; 32:1275-86.
• Duysinx B, Nguyen D, Louis R, Cataldo D, Belhocine T, Bartschet P, Bury T. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. Chest 2004; 125:489-93.
• Duyxinx BC, Larock MP, Nguyen D, Corhay JL, Bury T, Hustinx R, Louis R. 18-FDG PET imaging in assessing exudative pleural effusions. Nucl Med Commun 2006; 27:971-6.
• Kookoolis AS, Puchalski JT, Murphy TE, Araujo KL, Pisani MA. Mortality of hospitalized patients with pleural effusions. J Pulm Respir Med 2014; 4(3):184.
• Steiner CA, Friedman B. Hospital utilization, costs, and mortality for adults with multiple chronic conditions, Nationwide Inpatient Sample, 2009. Prev Chronic Dis 2013; 10:E62.